Blum Agnieszka

Executive Vice President & Board Member at Ardigen SA at Ardigen
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Poland, PL

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Poland
    • Biotechnology Research
    • 100 - 200 Employee
    • Executive Vice President & Board Member at Ardigen SA
      • Oct 2022 - Present

      Cracow, Małopolskie, Poland

    • General Director of the Immunology Business Unit
      • Oct 2020 - Present

      Cracow, Małopolskie, Poland

    • Ireland
    • Hospitals and Health Care
    • 700 & Above Employee
    • Consultant Haematologist / NGS Laboratory Lead
      • Oct 2016 - Aug 2020

      Dublin, Ireland

    • Ireland
    • Hospitals and Health Care
    • 700 & Above Employee
    • Consultant Haematologist
      • Oct 2016 - Mar 2020

      County Dublin, Ireland

    • Germany
    • Hospitals and Health Care
    • 700 & Above Employee
    • Production Quality Officer
      • Feb 2016 - Jul 2016

      Since 2016 I am a Production Quality Officer at Charité Stem Cell Facility where I: • develop, implement, and maintain the activities of flow cytometry based quality control processes for cellular products

    • Pharmacovigilance Manager
      • 2011 - Jul 2016

      Since 2011 I am the Pharmacovigilance Officer at Charité Stem Cell Facility where I: • develop and implement pharmacovigilance processes • prepare SOPs and perform trainings for the personal • prepare Individual Case Safety Reports as well as Suspected Unexpected Serious Adverse Reactions and report them to the authorities • prepare and submit periodic safety update reports

    • Development of clinical pathways
      • 2011 - Jul 2016

      In 2011 I developed a clinical algorithm for the extracorporeal photopheresis treatment of patients with acute and chronic GvHD. It consisted in: • Adaptating the process to the special on-side demands and current German regulations • Assignment of responsibilities to the involved personal at Charité Stem Cell Facility including: registration personal, doctors, nurses and laboratory staff • Providing explicit recommendations for treatment schedule and response… Show more In 2011 I developed a clinical algorithm for the extracorporeal photopheresis treatment of patients with acute and chronic GvHD. It consisted in: • Adaptating the process to the special on-side demands and current German regulations • Assignment of responsibilities to the involved personal at Charité Stem Cell Facility including: registration personal, doctors, nurses and laboratory staff • Providing explicit recommendations for treatment schedule and response evaluation • Developing standardized documentation charts and SOPs • Developing a quality control system and bio-banking procedures as well as a research data base • Performing staff-trainings including registration personal, nurses, doctors and laboratory personal In 2014 I supervised the development of a clinical algorithm for an autologous serum based eye-drops treatment of patients with ocular chronic GvHD. My job consisted in: • Defining the required product, product optimization and development of a manufacturing process conform to GMP-regulations • Supervising the development of standardized documentation and standard operating procedures • Co-Developing the phase II study protocol • Co-Developing commercialization and reimbursement strategies • Fundraising activities to guarantee the successful realization of the project (Max Rubner Preis) • Coordinating and supervising the project activities performed by doctors, nurses, manufacturing and quality control team

    • Academic Teacher
      • 2009 - Jul 2016

      Berlin Teaching of medical students in internal medicine, hematology and oncology. Lectures and workshops on the treatment of GvHD.

    • Consultant Haematologist; Medical Oncologist; Internal Medicine
      • Sep 2007 - Jul 2016

      Charité, Medical Department,Division of Hematology,Oncology and Tumor Immunology • Treatment of in- and outpatients with both solid and hematologic tumors. Responsible for the stem cell transplantation patients. Treatment of stem cell transplant patients that developed severe acute or chronic GvHD. • Diagnosis in hematology including cytology and flow cytometry. • Involvement in clinical trials in the treatment of hematological malignancies, particularly in cellular therapies.

    • Post-Doctoral scientist and project coordinator
      • Jan 2010 - Jun 2016

      Transregional collaborative research centre TR36 - Berlin and Munich University Coordinator - Project for the development of a platform for the clinical application of TCR-engineered T cells with defined specificity Project 1: Application of HMMR-TCR-transduced T cells after haploidentical stem cell transplantation for patients with refractory AML Project 2: Application of MAGE-A1-TCR-transduced T cells for treatment of patients with refractory and high-risk multiple myeloma. Project 3: Multicenter phase I/IIa study using T-cell receptor gene therapy… Show more Coordinator - Project for the development of a platform for the clinical application of TCR-engineered T cells with defined specificity Project 1: Application of HMMR-TCR-transduced T cells after haploidentical stem cell transplantation for patients with refractory AML Project 2: Application of MAGE-A1-TCR-transduced T cells for treatment of patients with refractory and high-risk multiple myeloma. Project 3: Multicenter phase I/IIa study using T-cell receptor gene therapy in metastatic melanoma (Eudractnr.: 2011-002941-36) Coordination consists in: • Project scheduling • Coordinating activities of multiple teams - research, manufacturing, clinical, pathology • Contact with vendors • Developing a target product profile and a risk assessment manual • Co-developing a GMP-compliant manufacturing process (In cooperation with Prof.Dr. DJ. Schendel - EUFETS research lab) • Writing and editing of phase I protocols • Co-developing a flow-cytometry based immune monitoring (in cooperation with Prof. Dr. B. Sawitzki research group - Berlin- Brandenburg Center for Regenerative Therapies- and Beckman Coulter) • Preparing and documenting PEI advisory meetings (PEI = Paul Ehrlich Institute) • Calculating costs and coordinating fundraising activities • Managing and moderating team and consultant meetings • Presenting the project at internal meetings and international conferences Show less

Education

  • Jagiellonian University
    Medicine
    2004 - 2006
  • Humboldt University of Berlin
    Medicine
    2003 - 2004
  • Jagiellonian University
    Medicine
    2000 - 2004
  • Humboldt University, Berlin:
    Doctoral Dissertation
    2013 -
  • FLIMS
  • Humboldt University of Berlin
  • The London School of Economics and Political Science (LSE)

Community

You need to have a working account to view this content. Click here to join now